TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,754 | +5.6% | 1,199 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $18,699 | +16.9% | 1,199 | +0.3% | 0.01% | 0.0% |
| Q3 2022 | $16,000 | -5.9% | 1,196 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $17,000 | +13.3% | 1,196 | +12.1% | 0.01% | +25.0% |
| Q1 2022 | $15,000 | 0.0% | 1,067 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $15,000 | -11.8% | 1,067 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $17,000 | -5.6% | 1,067 | 0.0% | 0.01% | -8.3% |
| Q2 2021 | $18,000 | -5.3% | 1,067 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $19,000 | 0.0% | 1,067 | 0.0% | 0.02% | -16.7% |
| Q4 2020 | $19,000 | – | 1,067 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |